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Sickle cell anemia is a genetic disease which leads to
the polymerization of hemoglobin and subsequent changes in
the membrane. The membrane alterations are thought to be
the cause of the major symptom of the disease, the vaso-
occlusive crisis.
The purpose of this investigation was to search for
alterations in the membrane skeleton of sickle cell
erythrocytes. The membrane skeleton is a protein network
which controls the shape and deformability of red blood
cells.
Several differences were detected between sickle and
normal membrane skeletons by using electron microscopy,
high resolving electrophoresis, crosslinking reagents, and
exogenous proteolytic enzymes.
Clarification of the mechanism responsible for these
alterations may lead to new therapy for sickle cell disease.
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Sickle cell anemia is a hereditary hemoglobin disorder.
Two types of red blood cells are present in the circulation
of individuals with the disease: irreversible sickled cells
(ISCs) and reversible sickled cells (RSCs). ISCs, unlike
RSCs, are fixed in a sickled shape. In addition to the
abnormal shape characteristic of ISCs, both types of cells
have several other cellular alterations, including reduced
cellular deformability (Hahn et al., 1976) and increased
cellular adhesivity (Hebbel et al., 1980). All of these
cellular abnormalities involve membrane alterations and
recent experiments suggest that they are a contributing
cause of the pathophysiology of the disease, particularly
the vaso-occlusive crisis.
Lux et al. (1976) demonstrated that the abnormal shape
of the ISC is due to a defect in the membrane skeleton. The
membrane skeleton of mature red blood cells is a complex of
peripheral proteins located on the cytoplasmic face of the
membrane. The skeleton comprises 60% of the total membrane
protein mass and includes spectrin (bands 1 and 2), actin
(band 5), bands 4.1, 4.9 and 7 (Sheetz, 1979). There is
reason to believe that a defect in the sickle membrane
skeleton may be responsible for the abnormal shape, rigidity
and increased adhesivity of sickle cells. Since it has been
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established that the ability to undergo changes in cell
shape, i.e., the ability to be deformed, is due to the
membrane skeleton (Lange et al., 1982), this implies that
the irreversible deformation of sickled skeletons should
lead to increased cell rigidity. In fact, studies by Chasis
and Mohandas (1986) indicated that defects within membrane
skeletal proteins contribute to abnormal cellular
deformability.
The increased adhesivity of sickle cells appears to be
due to an altered distribution of sialic acid on the surface
of the cell, which is associated with the integral membrane
protein, glycophorin. It has been shown that glycophorin is
attached to the membrane skeleton at the cytoplasmic surface
of the membrane (Fowler and Bennett, 1983) and that changes
in the organization of spectrin can affect the distribution
of negatively charged sites (presumably sialic acid) on the
surface of the cell (Nicholson and Painter, 1973).
Only one molecular defect has been identified and
associated with sickle cell anemia. A mutation was found in
the Beta-subunit of hemoglobin, whereby the amino acid
glutamic acid is substituted by the amino acid valine at the
sixth position (Ingram, 1956). This mutation causes the
defective sickle cell hemoglobin (HbS) to polymerize under
low oxygen tension, and as a consequence, the cell sickles
(Murayana, 1966). The skeletal defect and the other
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membrane associated abnormalitites are presumably due to
cell sickling.
In previous attempts to identify defects within sickle
skeletons, no differences in protein composition were
observed when analyzed by electrophoresis on Fairbanks gels
which were stained with coomassie blue (Lux et al., 1976).
The specific objective of this research was to search for
alterations in the composition and associations of proteins
in sickle membrane skeletons. In order to search for
alterations in the membrane skeleton, several approaches
were employed: 1) Transmission electron microscopy; 2) High
resolving electrophoretic systems in conjunction with
various protein stains; 3) Bifunctional crosslinking
reagents; and 4) Exogenous proteolytic enzymes.
Detection and characterization of defects within sickle
membrane skeletons may be beneficial in developing a
treatment to alleviate the vaso-occlusive crisis, and may




Sickle cell anemia is a hereditary disease
characterized primarily by the synthesis of abnormal sickle
hemoglobin, designated as HbS. Professor James B. Herrick
(1910), known for his work on coronary sclerosis, is
responsible for the first documentation of the disease.
While examining a blood smear from a black West African
student with chronic anemia, he observed numerous elongated,
crescent shaped cells which he called sickle cells.
Pedigree analysis of patients with the disease led to
the conclusion that the disease was inherited as a Mendelian
autosomal dominant characteristic (Taliaferro and Hack,
1923). However, several years later, Neel (1949) and Beet
(1949), independently reached the conclusion that the
disease represented the homozygous form (S/S). Therefore,
according to Mendelian principles, individuals with two
copies of the abnormal sickle hemoglobin gene have the
disease. Individuals with only one abnormal sickle gene
have the trait and are asymptomatic.
Sickle hemoglobin (HbS) was first detected by Pauling
et al. (1949) and the nature of the molecule was identified
several years later (Ingram, 1956). The abnormal hemoglobin
results from a point mutation that gives rise to a single
amino acid substitution, whereby the amino acid valine is
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substituted for glutamic acid at the sixth position of each
beta chain of adult hemoglobin. The amino acid substitution
leads to the polymerization of hemoglobin when the molecule
is in the deoxy-conformation (Bertles and Milner, 1968). As
a consequence, the cell shape is distorted into an abnormal
sickle shape.
Sickle cell anemics suffer from a broad spectrum of
clinical problems. Symptoms readily diagnosed are chronic
hemolytic anemia and pain crisis. Hemolytic anemia results
from the shortened life span of sickle red cells (Singer et
al., 1948; Callender et al., 1949).
The pain crisis is one of the distinguishing
characteristics of sickle cell disease. The crisis results
from local intravascular sickling, stasis and vaso-
occlusion. Pain occurs most frequently in the justa-
articular area of the long bones and is particularly obvious
in the elbows, wrists, shoulders, knees and ankles. The
severity of pain varies from mild transient attacks of 5-10
min to severe attacks which may persist several days or
weeks. Diggs (1965) has described the quality of the pain
as deep-seated, boring or like a tooth ache.
Several factors are believed to precipitate the pain
crisis. Infection is thought to precede the pain crisis and
it appears to occur more frequently in the African
environment (Konotey-Ahulu, 1971b). The exact mechanism
whereby infection precipitates the crisis is unknown.
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Several reports have implicated cold as a precipitating
agent (Diggs, 1965; Diggs and Flowers, 1971); however, no
controls were performed. In one case, the increase in
frequency of pain crisis was shown to be seasonal (Lehmann,
1968; Addae, 1971), and in a retrospective review in
Buffalo, New York, crisis occurred more frequently during
winter periods. Yet, the mechanism of cold related crisis
is obscure. Other crisis precipitating factors include
acidosis, pregnancy, emotional stress, hypoxia and
dehydration (Nagel and Portadin, 1977; Mahoney and Githens,
1979; and Diggs, 1965).
In the circulatory system of sickle cell anemics, there
exists a population of cells that are irreversibly sickled.
Unlike reversible sickled cells (RSC), irreversibly sickled
cells (ISCs) do not return to the normal biconcave shape
upon oxygenation. Irreversible sickle cells (ISCs) vary in
proportion in the circulatory system of sickle cell anemics
from an average of 5-50% (Diggs, 1956; Bertles and Milner,
1968; Sergeant et al., 1969). It has been proposed that
ISCs contribute to pain crisis, yet there is no positive
correlation between the percentage of ISCs and the frequency
at which the pain crisis occurs (Diggs, 1956). In an animal
model, it was shown that ISCs are preferentially lodged in
capillaries, suggesting that they may indeed play a role in
initiating vaso-occlusion (Klug et al., 1974).
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Erythrocyte deformability has been shown to decline
during the pain crisis (Kenny et al., 1981) and improve with
recovery from the crisis (Rieber et al., 1977). Kenny et
al. (1981) also demonstrated that decreased deformability
preceded the onset of pain crisis, although the study was
limited to one case study. Other hematologic indices
reported to improve with recovery of crisis include plasma
volume (Jenkins et al., 1956; Erlandson et al., 1960;
Berreras et al., 1966), leucocyte (Diggs, 1965; Buchanan and
Glader, 1978) and platelet counts (Freedman and Karpatkin,
1975) .
Sickle cell anemia is frequently associated with other
genetically determined abnormalities of either the alpha
( ) or beta ( ^ ) subunit of hemoglobin. This association
can effectively alter the expression and severity of the
pain crisis. The exact mechanism of modulation of the
expression and severity of the pain crisis is known in some
disorders, while in others, the mechanism remains obscure.
Typically, patients with S/C disease, a doubly heterozygous
condition for hb S and C, have infrequent crises and their
anemic condition is not as severe (McCurdy et al., 1975).
Hereditary persistence of fetal hemoglobin (HPFH) is
encountered in approximately 0.1% of blacks; these
individuals have 70% HbS, 20-30% HbF (the principle hb
present during fetal development) and low HbA2 (a minor
adult hemoglobin). Sickling of cells is rarely seen in these
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individuals and the expression of pain crisis is milder;
some individuals do not experience the pain crisis. It was
postulated that the mild expression of sickle HPFH is due to
the uniform distribution of fetal hemoglobin in sickle
cells, thus protecting red cells from sickling
(Stamatoyannopoulos et al., 1975). Coexistence of
thalassemia, a hemoglobinapathy resulting from a decreased
production of the alpha or beta polypeptide chain, with
sickle cell is, in general, associated with a milder disease
(Sergeant et al., 1973). Patients with alpha {o< )
thalassemia appear to have less frequent episodes of pain
and episodes occur less frequently than in individuals with
beta (^) thalassemia.
Sickle cells are easily separated into subfractions of
ISC and non-lSCs employing density centrifugation. Nagel
(1982) demonstrated four (4) distinct fractions (I-IV) of
hemoglobin S/S erythrocytes. Each fraction differed in
density and hemodynamic characteristics (erythrocyte flow
rate). In these same studies, ISCs (Fraction IV) and RSCs
were shown to become more dense upon deoxygenation (Fabry
and Nagel, 1982).
Both ISCs and dense RSCs have been implicated in
contributing to the pathophysiology of sickle cell disease.
Hemodynamic studies employing the Baez preparation (isolated
artificially perfused mesoappendix vasculature of the rat)
demonstrated that dense ISCs (Fraction IV) and very dense
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discocytes (Fraction III) differ in their flow rates in the
oxygenated state and, when deoxygenated, a progressive
increase in their difference was observed (Kaul et al.,1983). Under both high and low oxygen conditions, dense
ISCs moved slower than dense discocytes. It was suggested
that Fraction III cells are as detrimental to the
microcirculation as the ISC rich Fraction IV and perhaps
induce occlusion by a different mechanism (Nagel and Fabry,
1984).
Currently, the hemoglobin defect in sickle cells is the
only defect known at the gene level. However, it is
believed that the interaction of hemoglobin polymers and/or
denatured hemoglobin (heinz body) with the membrane causes
membrane alterations. Alterations that are closely
associated with the membrane include the abnormal shape of
sickle cells (Lux et al., 1976), decreased viscoelasticity
(Chien et al., 1970) and increased membrane adhesivity
(Hebbel et al., 1980). These abnormalities along with the
hemoglobin defect may contribute to the complexity and
severity of the disease.
Sickle cells characteristically adhere to endothelial
cells more avidly than normal erythrocytes. It has been
reported that sickle cells adhere abnormally to cultured
human or bovine endothelial cells (Hoover et al., 1919;
Hebbel et al., 1980). Deoxygenation of sickle cells does
not alter their adhesivity; however, other factors have been
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demonstrated to increase cell adherence such as fibrinogen
(Hebbel et al., 1981) and non-specific plasma factors
(Mohandas et al., 1984). The adherence of sickle cells to
endothelial cells varies from patient to patient and was
postulated to contribute to the pathophysiology of the
disease (Hebbel et al., 1980). The abnormal cell adhesivity
has been attributed to an altered surface charge of the red
cell membrane (Hebbel et al., 1980).
Several investigators have reported the electrophoretic
characterization of sickle membrane proteins. Riggs and
Ingram (1977) observed a decrease in band 3, an increase in
bands 4.5, 6 and 7, and the appearance of band 8
(hemoglobin dimer). Yet, other investigators (Durocher and
Conrad, 1974; Balias and Burka, 1980) failed to detect any
differences in protein composition between sickle and normal
membranes. The reasons for the discrepancies between these
studies could reflect the limited resolving power of the
techniques employed or perhaps differences in methods of
preparing membranes. To facilitate the detection of possible
differences in sickle membrane proteins, similar studies
employing techniques of greater resolution are warranted.
Stocks et al. (1972) was the first to demonstrate that
sickle cells are more susceptible to lipid peroxidation than
normal cells. This finding was also demonstrated by other
investigators (Das and Nair, 1980; Chiu and Lubin, 1979) who
reported that sickle cells have more malonaldehyde (MDA)
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than normal cells (Chiu and Lubin, 1979) and are deficient
in vitamin E which functions as a membrane antioxidant (Jain
and Shohet, 1984). In addition, sickle cells have a greater
tendency to form MDA ui vitro in comparison to normal cells.
Evidence of abnormal lipid peroxidation in sickle cells in
vivo has also been published (Das and Nair, 1980; Jain and
Shohet, 1984; Hebbel and Miller, 1984).
Results demonstrating membrane protein oxidation are
limited. Oxidation of proteins can lead to their
aggregation by several mechanisms, however, attempts to show
high molecular weight aggregates have been unsuccessful
(Palek and Lux, 1983). Recently through use of thiol-
disulfide exchange chromatography, sickle membrane proteins
were shown to be more oxidized than normal. Approximately
21% of total sickle membrane proteins partition in the
filtrate (oxidized/blocked thiol) fraction while only 13% of
normal erythrocyte protein was present in the filtrate (Rank
et al., 1985). Similar alterations were detected in
erythrocyte membranes from patients with other oxidative
hemolytic disorders (Rank et al., 1985).
The exact mechanism of increased membrane peroxidation
and accumulation of MDA is unknown, however, several
mechanisms may be involved: (1) the auto oxidation of
unstable sickle hemoglobin resulting in increased production
of H2O2 (Hebbel, 1982); (2) the presence of increased
intracellular calcium in sickle cells, which may potentiate
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the denaturation of sickle hemoglobin leading to membrane
peroxidation (Jain and Shohet, 1981); and (3) a deficiency
of vitamin E in sickle cells (Chiu and Lubin, 1979) which
could result in an increased concentration of oxidants. It
was suggested that the formation of a phospholipid-MDA
adduct contributes to peroxidative membrane damage and may
occur during ISC formation (Jain and Shohet, 1981).
Lubin et al. (1981) demonstrated that the phospholipid
organization of the plasma membrane is altered in
deoxygenated sickle cells. Deoxygenation accelerates
transbilayer movement of phospholipid (Franck et al., 1981),
thus increasing the exposure of the aminophospholipids
phosphatidylserine (PS) and phosphatidylethanolamine (PE) in
the external leaflet of the plasma membrane. It was
demonstrated by Franck et al. (1983) that the increased
transbilayer mobility observed in deoxygenated RSCs is
restored to normal upon reoxygenation, as indicated by
accessibility to external probes. The abnormal lipid
distribution seen in sickle cells was found to accelerate in
vitro clotting by 30% when compared to normal and oxygenated
RSCs (Chiu et al., 1981).
Beneath the lipid-protein bilayer, there exists an
interconnecting network of peripheral membrane proteins
called the membrane skeleton (Fig. 1). The membrane
skeleton is defined operationally as the insoluble fraction
obtained after a cell or membrane (ghost) has been extracted
Schematic diagram depicting the arrangement of
proteins in the membrane skeleton and their







with a non-ionic detergent such as Triton X-100. The
membrane skeleton has several putative functions including
control of: (1) cell shape (Yu et al., 1973; Lux, 1979);
(2) membrane deformability (Steck, 1974); (3) membrane
stability (Marchesi et al., 1969); and (4) lateral mobility
of transmembrane proteins (Elgsaeter and Branton, 1974;
Palek and Liu, 1979).
The most striking evidence for shape control by the
skeleton was provided by Lux et al. (1976), who showed that
membrane skeletons extracted from ISCs exhibited shape
alterations similar to that of the intact cell. It has also
been shown that skeletons prepared from hereditary
elliptocytes (HE) (Tomaselli and Liu, 1977) and hereditary
pyropoikilocytes (HPP), cells with multiple protrusions
(Lux, 1979, Palek et al., 1981), exhibit alterations similar
to those observed in the intact cells. Defects within the
skeleton of cells from HE and HPP are better understood than
in sickle cells and clearly suggest a cause and effect
relationship between the membrane skeleton and the red cell
shape.
The membrane skeleton was first implicated in
modulating membrane stability when it was noted that
membrane fragmentation occurred after the extraction of the
major skeletal constituent, spectrin (Marchesi et al., 1969;
Fairbanks et al., 1971). Additional evidence comes from the
study of a mutant strain of the mouse Mus musculus, which
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exhibits a severe form of spherocytic anemia. Erythrocyte
membranes from the mutant show a marked decrease in spectrin
(Greenquist et al., 1978). Spectrin deficiency correlates
with the degree of hemolysis (Lux, 1979) and incorporation
of normal spectrin into these membranes results in improved
structural integrity (Shohet, 1979). A role of erythrocyte
skeletons in the control of membrane stability is further
indicated by experiments on skeletons with known defects in
membrane stability. Hereditary Elliptocytes (HE) are
fragile and their membrane skeletons are more unstable than
normal. In some patients, membrane instability is
correlated with unstable spectrin, as evidenced by the fact
that spectrin is abnormally heat sensitive and denatures at
a lower temperature than normal (Tomaselli et al., 1981).
In other patients, skeleton instability seems to be due to
an abnormality in spectrin affecting the dimer-tetramer
equilibrium and the absence of protein 4.1 (Cohen and
Branton, 1981; Tachenai et al., 1981). Skeletons from HPP
also exhibit reduced stability which may be due to unstable
spectrin. It has been shown that HPP spectrin exhibits
increased susceptibility to thermal denaturation (Chang et
al., 1979).
Flexibility of the membrane is conferred by the two-
dimensional skeletal network. The control of this cellular
property is best illustrated in cells where the membrane
skeleton is altered. In some patients with Hereditary
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Spherocytes (HS), membrane skeletons showed reduced
deformability when measured with the ektacytometer (a laser
diffraction technique), and the skeleton protein 4.1 and
spectrin interaction was defective (Cohen and Branton,
1981). However, in other HS patients, these defects are not
observed, implying that other membrane alterations may lead
to the reduced deformability characteristic of HS cells. It
is well established that sickle cells are less deformable
than normal cells (Usami et al., 1975; LaCelle, 1970; Lessin
et al., 1977). Recent studies indicate that defects within
skeletal proteins contribute to the abnormal deformability
of these cell (Chasis and Mohandas, 1986; Clark et al.,
1980a; Clark et al., 1980b, Gulley et al., 1982).
The role of the membrane skeleton in controlling
surface mobility is based, in part, on measurement of
movement of fluorescently labeled band 3 in fused cells.
These studies showed that detachment of spectrin from the
membrane (Fowler and Bennett, 1978) and its absence in cells
(Nicholson and Painter, 1973) are associated with a marked
increase in lateral mobility of band 3. In addition,
changes in spectrin organization, such as spectrin
aggregation, is accompanied by aggregation of intramembrane
particles, which are transraembrane protein complexes
(Nicholson and Painter, 1973). The altered adhesivity seen
in sickled cells may be due to a defect in the skeleton
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which alters the distribution of proteins on the surface of
the cell by altering the location of transmembrane proteins.
Membrane skeleton proteins constitute approximately 60%
of the total membrane protein mass and include the
following; Spectrin (bands 1 and 2), Actin (band 5)# bands
4.1, 4.9 and 7 (Sheetz, 1979). Other proteins found
associated with the membrane skeleton are Ankyrin (bands
2.1, 2.2, 2.3, and 2.6), bands 3 and 4.2. These latter
proteins are not considered to be integral components of the
skeletal network. The functions and the associations of
bands 4.9 and 7 in the skeleton are unclear, while band 3
appears to be the major anion channel in the membrane
(Rothstein et al., 1979). Ankyrin attaches the skeleton
network to the membrane via the cytoplasmic domain of band
3. The function of band 4.2 has not yet been defined.
Spectrin is the major protein of the network and
comprises about 75% of the skeleton protein mass (Lux et
al., 1976). It is comprised of two subunits, band 1 (en¬
chain, molecular weight 240 kilodaltons) and band 2 (^ -
chain, molecular weight, 200 kilodaltons). The two subunits
are structurally similar but nonidentical (Anderson and
Tyler, 1979). They have similar amino acid composition and
share many homologous repeating units of amino acid
sequences (Hsu et al., 1979). Spectrin exists as a
heterodimer (1+2) or heterotetraraer (1+2)2 (Ralston et al.,
1977). The tetramer is thought to be the physiologic
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species in the erythrocyte (Ungelwickell and Gratzer, 1978;
Liu and Palek, 1980; Ji et al., 1980). With the use of red
cell anti-spectrin antibody, a host of non-erythroid
spectrin molecules have been identified (Goodman et al.,
1981; Glenney et al., 1982; Bennett et al., 1982; Repasky et
al., 1982; Burridge et al., 1982). Fodrin, the brain
analogue of spectrin, is the most completely described of
the spectrin family (Goodman and Zagon, 1984). Fodrin is
thought to play essentially the same role in neuron axons as
spectrin in red blood cells (Riederer et al., 1986). The
subunits of the non-erythroid variants differ in size, with
the ^-subunit exhibiting greatest heterogeneity.
Protein 4.1 consists of two polypeptides, designated as
4.1a and 4.1b with molecular weights of 80,000 and 78,000
daltons, respectively. Both polypeptides are similar in
amino acid composition and are sequence-related
phosphoproteins (Goodman et al., 1982). Protein 4.1 plays
an integral role in maintaining the supramolecular structure
of the membrane skeletal complex. Fowler and Tyler (1980)
reported that an oligomeric complex of spectrin, actin and
4.1 causes actin to gel and that purified spectrin and actin
monomers lack this activity, suggesting that band 4.1 is
required for crosslinking. Similar observations have been
reported by other investigators (Ungelwickell et al., 1979;
Cohen et al., 1980). Tyler et al. (1980) reported that
purified band 4.1 binds to spectrin in the absence of actin
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indicating a specific interaction of 4.1 with spectrin.
Protein 4.1 contributes to the structural stability of the
membrane skeleton by enhancing the interaction between
spectrin and actin. This proposed function of protein 4.1
is supported by the observation that erythrocytes from
patients deficient in protein 4.1 are more fragile than
normal (Tchernia et al., 1981; Aloisio et al./ 1982a, 1981,
1983; Wolfe et al., 1982; Goodman et al., 1982).
Several studies indicate that protein 4.1 serves as a
substrate for a number of erythrocyte kinases (Hosey and
Tao, 1976; Ling and Sapirstein, 1984; Horne et al., 1985).
Phosphorylation of protein 4.1 is enhanced by either a
cyclic-AMP independent or dependent kinase (Avruch and
Fairbanks, 1974; Hosey and Tao, 1976; Simkowski and Tao,
1980), or by a Ca/phospholipid dependent kinase (Ling and
Sapirstein, 1984; Horne et al., 1985). It was demonstrated
that the kinases differentially phosphorylate multiple sites
in the 4.1 protein and that the phosphorylation sites are
localized within a 10 kilodalton peptide. The function of
phosphorylation of protein 4.1 is unclear, however, it is
conceivable that the phosphorylation of 4.1 regulates the
interaction between spectrin and actin and also the binding
of 4.1 to other sites within the inner membrane.
Immunoreactive isoforms of protein 4.1 exhibit a broad
range in apparent molecular weight (m.w.) of 69-175
kilodaltons (kd) and are found in a variety of non-erythroid
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cells (Cohen et al., 1982). The different isoforms of
protein 4.1 have not yet been characterized functionally;
however, in avian lenticular cells, the expression of 4.1 is
variable and appears to be regulated during development,
suggesting that the different isoforms are functionally
different (Granger and Lazarides, 1985). Non-erythroid 4.1
has also been detected in stress fibers (Cohen et al.,
1982), bovine lens (Aster et al., 1984), brain (Goodman et
al., 1984), platelets (Davies and Cohen, 1985) and many
other cell types (Baines and Bennett, 1985).
Erythrocyte actin in the membrane skeleton exists in a
filamentous state (i.e., F-actin) (Finder et al., 1975;
Tilney and Detmers, 1975). Actin filaments are not visible
in electron micrographs of red cell membranes and the amount
of actin is not compatible with the existence of long actin
filaments; however, short filaments exists. Red cell
membranes were shown to contain binding sites of high
affinity for cytochalasin (Lin and Lin, 1978), which
attaches to actin filaments and not to G-actin (globular or
monomeric actin) (Brown and Spudich, 1979; Flanagan and Lin,
1980; Brenner and Korn, 1980). In addition, covalent dimers
and trimers of actin are detected when the membrane is
exposed to bifunctional crosslinking reagents (Wang and
Richards, 1975; Lin and Palek, 1979), suggesting a close
proximity of actin subunits to one another. Atkins et al.
(1982) have isolated short actin filaments containing 30
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subunits from membranes in the presence of phallodin, a
chemical which stabilizes actin filaments. Erythrocyte
actin is similar to muscle actin in size, has the ability to
polymerize into 90 A filaments, is decorated with heavy
meromyosin (Tilney and Detmers, 1975) and stimulates myosin
ATPase activity (Sheetz et al., 1979).
Band 4.9 (molecular weight, 48 kilodaltons), a minor
protein of the membrane skeleton, has been biochemically
characterized as a trimeric actin-bundling protein and
interacts with actin to form actin filaments (Siegel and
Branton, 1985). Band 4.9, like protein 4.1, is also
phosphorylated by cAMP-dependent kinases. Protein 4.9
appears to be a more suitable substrate for cAMP-dependent
kinase while 4.1 is more suitable for Ca/phospholipid
dependent kinase (Leto and Marchesi, 1985), and the kinase
for 4.9 is membrane bound unlike the kinase for 4.1
(Fairbanks and Avruch, 1974; Guthrow et al., 1972; Rubin,
1978; Thomas et al., 1979). Interestingly, the degree of
phosphorylation of protein 4.9 is greater in sickle cells
than in normal cells (Dzandu and Johnson, 1980). It has
been proposed that protein 4.9 stabilizes the membrane
skeleton, just as protein 4.1 (Holdstock and Ralston, 1980,
1983).
The appearance of the skeleton has been described as a
continuous fibrillar reticulum (Hainfield and Steck, 1977;
and Sheetz, 1979). Unit fragments of skeletons have been
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identified (Shen et al., 1986) and appear to contain linear
filaments approximately 708 nanometers (nm) in diameter,
from which several slender and convoluted filaments project.
On the basis of biochemical studies, the linear filaments
were identified as F-actin and the convoluted filaments as
spectrin (Byers and Branton, 1985). Spectrin molecules were
attached to clusters of actin filaments with a preference
for the ends of the filaments (Byers and Branton, 1985).
This ultrastructural arrangement gives rise to a hexagonal
appearance when unit fragments are attached in intact
skeletons (Shen et al., 1986). Thickened actin
protofilaments are also seen in micrographs in the above
study, which are presumably due to the presence of
associated proteins.
Biochemical and microscopic dissection of the membrane
skeleton has led to a working model of how proteins are
arranged (Branton et al., 1981; Marches!, 1985). The
spectrin subunits form double-stranded flexible heterodimers
(Branton et al., 1981) and assemble in a head-to-head
fashion to form tetramers (Morrow et al., 1981; Marches!,
1983). Short actin filaments bind to the distal ends of the
bivalent spectrin tetramers (Cohen, 1983). Labeling
studies showed that two moles of band 4.1 bind to one mole
of spectrin heterodimer (Tyler et al., 1980). Proteins 4.1a
and 4.1b bind with equal affinity to the spectrin subunits
(Cohen et al., 1983) and the 4.1 and actin are localized at
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the tail ends of spectrin tetramer. There are at least
three sites of interaction between the membrane skeleton and
the inner leaf of the bilayer. Protein 4.1 interacts with
the membrane glycoprotein designated as band 3 on SDS-gels
(Pasternack et al., 1985) and with glycophorin A (Anderson
and Loviein, 1984). The third point of attachment for the
membrane skeleton to the membrane is provided by ankyrin, an
accessory skeletal protein. Ankyrin binds to both spectrin
and band 3 (Bennett, 1982).
Evidence for the regulation of skeleton interactions
and function is limited, however, studies suggest that
phosphorylation may play a role. Spectrin, band 4.1 and
several accessory proteins (ankyrin and band 3) all have the
capacity to be phosphorylated (Guthrow et al., 1972;
Fairbanks and Auruch, 1974, 1974; Hosey and Tao, 1976).
Nakao (1974) observed that shape was affected reversibly as
a function of intracellular ATP. Although there is no
convincing evidence to demonstrate the regulation of the
skeleton network by phosphorylation of spectrin (Marchesi,
1983), it has been demonstrated that phosphorylation of
ankyrin reduces its affinity for spectrin tetramers but not
dimers (Lu et al., 1985), and also that phosphorylation of
4.1 causes a reduction in its affinity for spectrin (Eder
et al., 1985).
Skeletal defects within sickle cells are not as clearly
defined as in the previously discussed hemolytic anemias.
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although several lines of circumstantial evidence suggest
that the membrane skeleton is defective. Membrane skeletons
extracted from ISCs retain the distorted sickle shape (Lux
et al., 1976). Moreover, sickle spectrin binds to inside
out vesicles (lOVs) with lower affinity than normal
spectrin, providing additional evidence for a skeletal
defect in sickle cells (Platt et al., 1985).
Nonetheless the exact nature of the defect(s) in sickle
skeletons has not been determined. It is plausible that
defects in the membrane skeleton could account for the
abnormal deformability and adhesivity of all sickle cells as
well as the abnormal shape which is characteristic of the
ISC fraction. Detection of alterations and definition of
the mechanism(s) responsible for that occurrence could lead




Sickle cell blood was obtained from the Sickle Cell
Foundation of Georgia, Inc. in Atlanta, Georgia. It was
obtained from individuals who had been identified as
homozygous for the sickle (S/S) gene. These individuals had
not been transfused within a three month period prior to
phlebotomy. Normal (A/A) blood was obtained from paid
volunteers. Blood was processed immediately or stored at
11°C in the refrigerator.
SEPARATION OF IRREVERSIBLE SICKLED CELLS (ISCs)
Blood was transferred to clinical centrifuge tubes and
centrifuged for ten minutes (min) in a Dynac Clinical
centrifuge at 100 rpm at 4°C. The plasma and buffy coat
were removed and discarded. The remaining packed cells were
suspended in wash buffer called 5PN(8) (0.15M NaCl, 5mM
NaP04, pH 8), centrifuged as above and the supernate
discarded. The procedure of Abraham et al. (1975) was
adopted for separating ISCs. Dextran - 40 solutions of
various concentrations were prepared by dissolving
appropriate quantities in a medium consisting of 48 mg
KH2PO4, 3141 mg NaH2P04*H20, 8600 mg glucose, 6277 mg NaCL,
96 mg MgS04 with water added to make the total volume 1000
ml (pH 7.4). A volume of 1.5 to 2.0 milliliters (ml) of
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blood was layered on a Dextran-40 (molecular weight, 40,000)
discontinuous gradient ranging from 24% to 34% with a 60%
cushion to prevent pelleting of cells (Fig. 2). The total
volume in the centrifuge tube was 34 ml; each layer of
dextran solution consisted of 4.5 ml. Blood was
centrifuged in a Beckman 25.1 swinging bucket rotor in a
Beckman L5-50 ultracentrifuge at a speed of 90,000 x g
(24,000 rpm) at 4°C for 1.5 h. Centrifugation of cells
(normal and sickle) resulted in the separation of six
distinct bands of red blood cells. The bottom band in the
sickle gradient appeared darker in intensity than the normal
bottom band. Starting at the top of the gradient, the two
closest fractions were combined to yield three fractions
varying in the percentage of ISCs: top fraction
(approximately 9%), middle fraction (approximately 20%) and
the bottom fraction (approximately 71%). Cells were washed
twice in 5PN(8) and ultimately collected by centrifuging in
an International Equipment Centrifuge (lEC) for 10 min at
35,000 X g (16,000 rpm). The supernate was discarded.
SCORING OF ISCs
Packed cells were resuspended in 5PN(8) and incubated
under 95% oxygen and 5% carbon dioxide for 5 min with mild
agitation. An aliquot of suspended blood was removed and
fixed in 4% glutaraldehyde in 5PN(8) solution. Cells from
each fraction were viewed with a Swift International Phase
Contrast Microscope. ISCs were defined as elongated
Fig. 2. Diagrammatic representation of the Dextran - 40
step gradient used to fractionate erythrocytes.
Each layer consisted of 4.5 ml of the











34 milliliters total capacity
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crescent shaped cells whose length to width ratio was
greater than 2:1. A total of 500 cells were counted to
determine the percentage of ISCs in each fraction. Normal
cells were also viewed with the phase contrast microscope to
determine if the fractionating conditions altered the cell
morphology.
PREPARATION OF MEMBRANES AND SKELETON COMPLEXES
The method of Fairbanks et al. {1971) was employed for
preparing membranes (Fig. 3). Packed intact cells were
washed three to four times with an isotonic buffer [5PN(8)]
in a clinical centrifuge and then lysed in a hypotonic
solution called 5P(8) (5 mM sodium phosphate, pH 8.0). They
were subsequently washed three to four times in the same
buffer using the lEC centrifuge.
Skeletal complexes from membranes were prepared
according to the procedure of Sheetz (1979) (Fig. 4).
Membranes (3-4 mg protein/ml) were suspended 1:1 (v/v) in
extraction buffer {6M KCl, 48 mM Hepes/Ringer (pH 7.4), 1.0
mM MgCl2, 0.05 mM CaCl2). The suspended membranes were
extracted for 30 min at 4°C (in an ice bath) at 120
oscillations per min on a rotary shaker. Samples were then
centrifuged for 30 min in the lEC at 65,000 x g at 4°C. The
supernate was aspirated and discarded; the pellet (skeletal
complexes) was resuspended in 5PN(8) and washed until free
of hemoglobin. The washed pellet was resuspended in 5PN(8)
at a concentration of three to four milligrams (mg) protein
Fig. 3. General scheme for analyzing membrane proteins.
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(WASH RBCi 3x i,N 5pn(8) buffer(0.15m NaCL. .005m NaPOi, PH.8)AND DISCARD SUPSRNATE
I membranes were SOLUBILIZED IN SOScontaining buffer and SUBJECTEDTO ELECTROPHORESIS
TYPICAL APPEARANCE OF 4? ACRYLAMIDE
CYLINDER GEL. AFTER STAINING WITH COOMAS-
SIE BLUE AND DESTAINING
Fig. 4. General scheme for preparing membrane skeletons
from membranes and intact red blood cells, and
for analyzing their protein composition.
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TYPICAL appearance OF SKECETON
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per ml. The skeletal protein concentration was assayed by
the Bio Rad method.
SOLUBILIZATION OF WHOLE CELLS
Fifty microliters (ul) of packed cells were washed in
5PN(8) in the presence and absence of the proteolytic
inhibitors, 2 mM diisopropylfluorophosphate (DFP) or 3 mM
phenylmethylsulfonyl fluoride (PMSF), and then immediately
lysed and solubilized in a solution containing 150 ul
distilled water, 200 ul Laemmli (1971) sample buffer, 80 ul
20% SDS and 12 ul of 100% 2-mercaptoethanol. The mixture
was heated for 2 min at 100°C and allowed to cool before
electrophoresis or storage at -20®C.
CROSSLINKING OF SKELETAL COMPLEXES
The chemical structures of the crosslinking reagents
used in this study are shown in Figure 5. The procedure
used for crosslinking membrane skeletons with each of the
reagents is described below.
0-phenanthroline/Copper Sulfate (O-phe/CuSOa). O-
phe/CuS04 dissolved in 5 mm Sodium Phosphate buffer, pH 8.0
[5P(8)] was added to 20 volumes of skeleton suspension
(i.e., 50 ul 0-phe/CuS04 to 1.0 ml of skeleton suspension).
Skeletons (0.73 mg protein/ml) were crosslinked with O-
phe/CuS04 (Steck, 1972) at various concentrations ranging
from 0.01 mM to 0.1 mM. Incubations were carried out at
room temperature on a rotary shaker at 120 oscillations per
min at various time intervals, from 0 to 60 min. The
Fig. 5. Chemical structures of crosslinking reagents
employed. A) 0-phenanthroline/copper sulfate
(0-phe); B) Dithiobis (succinimidylpropionate)
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oxidative crosslinking reaction was stopped using 4X
Fairbanks solubilizing buffer (4% SDS, 8 mM Tris Acetate,
20% sucrose and Pyronin-y). Solubilization buffer was added
in an amount equivalent to one fourth the volume of the
reaction mixture. Dithiothreitol (0.0248 grams (gm) per ml
of solubilizing buffer) was included in the buffer added to
control skeletons to disrupt oxidative crosslinkages formed
endogenously or during incubation (i.e., skeletons which
were not incubated with crosslinking reagent).
Dimethyl 3,3 '-Dithiobispropionimidate (DTBP). Skeletons
were suspended in 0.05 M Triethanolamine buffer (pH 9.0) at
a final concentration of 0.73 mg protein per ml. DTBP
dissolved in the same buffer was added in a 1:1 (v/v) ratio
and the skeleton suspension was incubated at room
temperature at various times and concentrations of DTBP.
Crosslinking was terminated with 50 ul of 1 M ammonium
acetate (NH3AC) per ml of sample. The reaction mixture was
then incubated at room temperature for ten min and
subsequently 50 ul of N-ethylmaleimide (NEM) (20 mg per ml)
and 200 ul of 20% (w/v) SDS were added (Wang and Richards,
1974). One mg/ml of Pyronin-y was included as a tracking
dye.
Dithiobis (succinimidyl propionate) (DTSP). Skeletons
were suspended in 0.05 M Triethanolamine buffer (pH 8.0) at
a final concentration of 1.0 mg/ml. DTSP (4 mM) dissolved
in the same buffer was added in a 1:5 (v/v) ratio and the
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skeleton suspension was incubated at room temperature at
various times and concentrations of DTSP. Crosslinking in
the reaction mixture (0.5 ml) was terminated with 200 ul of
20% (w/v) SDS in 25 mM NaP04, 1 mM MgCl2f pH 8, and 1 mg/ml
of Pyronin y (Branton, 1980).
CROSSLINKING OF WHOLE CELLS
Dimethyl 3, 3'-Dithiobispropionimate (DTBP). Whole
cells were washed as described in the membrane preparation
section. A 25% red cell suspension was prepared in 5PN(8).
To prevent cell lysis, each crosslinking reagent (0-
Phe/CuS04, DTBP, and DTSP) was prepared in 5PN(8) buffer.
One volume of crosslinking reagent was added per volume of
cell suspension, with a final concentration of 25 mM, 24
mg/ml and 10 mM, respectively. To maximize crosslinking of
intact cells, the reaction mixture was initially incubated
for periods up to 2 h; However, cell lysis occurred when
incubation exceeded one hour. Therefore, the cell
suspension was routinely incubated for 60 min at room
temperature while gently shaken on a rotary shaker at 120
oscillation per min. At the end of the incubation period,
100 ul of the reaction mixture was solubilized as described
in the section on solubilization of whole cells,
mercaptoethanol was not included in the solubilization
buffer. Samples were vortexed vigorously and boiled for 1
min at 100°C. Crosslinked cell proteins were
electrophoresed on Fairbanks (4%) tube gels for the first
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dimension and then electrophoresed on SDS gels (Laemmli,
1971) for the second dimension (2-D diagonal electrophoresis
described in methods). Gels were routinely stained with
coomassie blue.
LIMITED PROTEOLYTIC DIGESTION
The procedure of Marches! et al. (1984) was employed
utilizing a battery of proteolytic enzymes. Membrane
skeletons, at a protein concentration of 0.73 mg/ml, were
reacted with either trypsin (0.1 mg/ml), chymotrypsin (0.1
mg/ml) or pepsin (0.01 mg/ml). A volume of 0.5 ml of
skeletons [suspended in 5P{8)] was reacted with the above
enzymes dissolved in 5P(8). The reaction mixture was
incubated over a period of 1 to 3 min at room temperature
while being shaken at 120 oscillations per min. The enzyme
reaction was terminated by the addition of an equal volume
of 0.4 mM DPP in 5P(8), and subsequently solubilized with
Laemmli solubilization buffer.
SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE)
One dimensional polyacrylamide gel electrophoresis was
performed as described by Fairbanks et al. (1971) and
Laemmli (1970). Four percent cylindrical (5 mm inside
diameter (i.d.) x 10.5 cm) Fairbanks gels were prepared from
a stock of 30% acrylamide and 0.8% bisacrylamide. The
Laemmli system was used to prepare slab gels.
Polyacrylamide slab gels were prepared in the Hoeffer
Vertical Slab Apparatus, with glass plate dimensions of 1.5
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nun X 14 cm X 18 cm. After the plates were assembled, 5% and
15% acrylamide solutions were prepared and sucrose added to
the more concentrated solution to a final concentration of
13%. Each solution had a total volume of 15 ml. Seven
microliters (ul) of tetramethylethylenediamine (TEMED) and
70 ul of 10% ammonium persulfate (catalysts) were added to
the 15% solution and the solution was then poured into the
exit chamber of a linear gradient maker. The valve
connecting the two chambers was briefly opened to allow back
flow to the 15% solution to prevent entrapment of bubbles in
the canal between the two chambers. After adding 7 ul of
TEMED and 70 ul of 10% ammonium persulfate, the 5%
acrylamide solution was subsequently added to the other
chamber of the gradient apparatus. Stirring bars were added
to each chamber, and the exit port and valve between the
chambers was opened. The acrylamide gradient solutions
exiting the gradient maker filled part of the volume between
the two plates in the gel apparatus. The acrylamide
solution between the two plates was subsequently overlayered
with butanol and allowed to polymerize for 1 h. After the
separating gel was polymerized, the butanol overlayer was
removed and replaced with Laemmli electrophoresis buffer.
The gel was allowed to stand overnight at room temperature.
The overlayer solution was then removed and, after blotting
the separating gel interface with a soft tissue, a 4.5%
stacking gel solution was poured on top. A 10-well comb was
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inserted into the stacking gel prior to polymerization to
form the lanes for application of the samples. After 30
min, the comb was carefully removed from the polymerized gel
and the residual unpolymerized gel solution aspirated.
The base of the gel chamber was removed and the gel was
placed inside the lower buffer reservoir. The upper and
lower reservoirs were filled with electrophoresis buffer and
the samples applied in the various lanes. A cannular
(pipette bent at the end) was used to remove bubbles from
the bottom of the glass plates. The power supply was
adjusted to 20 ma per gel and electrophoresis was terminated
when the tracking dye was at the end of the gel. The gel
was then removed from the glass plates and placed in 0.05%
Coomassie blue R-250, 25% isopropyl alohol, 15% acetic acid
(Fairbanks et al., 1975), where it was stained a minimum of
12 h. Subsequently, it was destained in 10% isopropyl
alcohol and 10% acetic acid. After destaining, the gel was
viewed upon a fluorescent lamp box.
ISOELECTRIC FOCUSING (lEF)
Isoelectric Focusing was performed as described by
O'Farrell (1975). Ampholytes were omitted from the
solubilization buffer and the urea concentration in the
buffer was adjusted to its saturation point. Gels were
poured as described by O'Farrell (1975) and overlayered with
butanol. After 2 to 3 h, the butanol was replaced with 20
ul of sample overlayer solution and the gel was allowed to
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polymerize for another 1 to 2 h. After polymerization, gels
were mounted in the standard cylindrical gel apparatus.
They were prefocused for 15 min at 200 volts, 30 min at 300
volts, and finally 30 min at 400 volts. The upper (cathode)
gel chamber was filled with fresh 0.025 M NaOH, which had
been degassed by boiling and stored in a tightly sealed
container. The lower (anode) reservoir was filled with 0.03
M H2PO4.
One volume of protein sample at a concentration of 3-4
mg/ml was diluted in 0.5 ml of 2% (w/v) NP-40 and 5% Beta-
mercaptoethanol. Samples were vortexed and boiled for five
min and again subjected to mixing. They were then cooled in
a cold water bath and crystalline urea was added to a
concentration of 9 M. Samples were then centrifuged in a
Brinkman Micro Centrifuge for two min and the supernate was
applied to the first dimension tube gel (lEF) and
overlayered with diluted sample overlayer solution.
Electrophoresis was performed at 400 volts for 12 h and
800 volts for the 13th h. Proteins were identified by the
staining procedure of Tuszynski et al. (1978).
A blank isofocused gel was used to determine the pH
gradient upon completion of electrophoresis. Gel pH was
measured with an automatic single contact electrode
connected to a standard pH meter. In some cases, pH
readings were made after cutting a blank gel into 5 mm
slices and placing each in 2 ml of degassed water, where
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they were shaken for 5 to 10 min. The pH of each solution
was subsequently determined with a pH meter.
Isofocused gels to be subjected to SDS-electrophoresis
(second dimension) were not stained but equilibrated with 5
ml of 0.0625 M Tris-HCl, pH 6.8, 2% SDS, 10% glycerol and 5%
Beta-mercaptoethanol for 1 min by mild agitation.
TWO-DIMENSIONAL POLYCRYLAMIDE GEL ELECTROPHORESIS (lEF/SDS
PAGE)
After equilibration, isofocus gels were sealed on top
of the stacking gel with a 1% agarose solution.
Electrophoresis was initiated at 100 volts until the dye
front entered the separating gel and then the voltage was
increased to 125 volts. Electrophoresis was ended when the
tracking dye reached the bottom of the gel. Gels were
removed from the vertical apparatus and stained according to
Fairbanks et al. (1971).
TWO-DIMENSIONAL DIAGONAL SDS-POLYACRYLAMIDE GEL ELECTROPHO¬
RESIS (2-D SDS-PAGE)
The procedure of Wang and Richards (1974) was employed
for 2-D SDS-PAGE with some modifications. Slab gels were
prepared for the second dimension (2-D) as described above
using a 4%-17% linear gradient. The gel solution was poured
up to a level approximately 2 cm from the top of the glass
plates. A 4.5% stacking gel was poured to the top and
overlayered with butanol. After polymerization, the butanol
was replaced with a solution containing 0.0248 gm DTT per ml
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and 1 mg/ml Pyronin-y. This was allowed to percolate into
the gel for a minimum of 30 min. The solution was removed
prior to applying the first-dimension (1-D) gel.
SILVER STAINING PROCEDURE (Bio-Rad)
Polyacrylamide slab gels were agitated in 40% methanol
(MeOH) - 10% HAc for 30 min, and after decanting the above
solution, the gels were agitated in 10% ETOH - 5% HAc for 15
min. The latter solution was replaced with a fresh solution
and agitation was continued for 15 min.
After removing ETOH - HAc, oxidizing solution (Bio Rad)
(20 ml commercial stock dissolved in 180 ml deionized water)
was added to the gel. The gel was allowed to stand in this
solution for 20 min with occasional shaking. The oxidizing
solution was decanted and the gel washed once with deionized
water. The gel was then placed in silver reagent (20 ml
stock silver solution added to 180 ml deionized water) for
20 min with mild agitation and washed with deionized water
until the gel became clear.
Developing solution (Bio Rad) [entire contents (25
grams) of commercial stock plus 3.6 L of deionized water]
was added to the gel after removing the water wash. The gel
was allowed to stand in developer for 30 sec with constant
agitation, before the solution was replaced with fresh
developer. The gel was then allowed to stand for 5 min in
the latter solution with gentle agitation. This last step
was repeated until the bands reached the desired intensity.
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Development was stopped by decanting the developer and
adding 5% HAc. Gels were subsequently stored in this latter
solution.
SILVER STAINING PROCEDURE (Tsanq et al., 1984)
Polyacrylamide slab gels were processed similarly to
the Bio-Rad procedure for the fixative steps (1 and 2).
After removing the ETOH-HAC, 10% glutaraldehyde was added to
the gel. The gel was allowed to stand in this solution for
30 min with occasional shaking. The glutaraldehyde solution
was decanted and the gel was washed in deionized water
several (3-4) times, 10 min in each wash. The gels were
occasionally stored overnight at this step. After washing,
the water was decanted, a solution of DTT (10 ug/ml) added
and the gel shaken intermittently for 30 min. The gel was
then rinsed once for 30 s in deionized water and a freshly
prepared solution of silver nitrate (0.012 mM) added. The
gel was shaken in this solution for 30 min, and then washed
with deionized water for 30 s. After washing, the gel was
rinsed rapidly twice in developing solution [0.28 M Na2C03
with HCHO (0.5 ml of 40% formamide per liter)]. Fresh
developing solution was added to the gel with mild
agitation, and the gel was shaken until the bands reached
the desired intensity. Development was stopped by decanting




Commercial Gelcode kits (Pierce Chemical Co.) were
employed to stain 1-D gels. Briefly, polyacrylamide slab
gels were fixed by shaking in ethanol-acetic acid (50% - 5%)
solution overnight, or for 2 h in 5% ethanol-10% acetic acid
solution. After fixing gels for 2 h, the ethanol-acetic
acid solution was decanted and the gel was washed with
deionized water for 1 h with 4 changes of fresh water every
15 min. After the final wash, the gel was stained in the
silver concentrate working solution (11 ml of silver
concentrate plus 165 ml of water) for 1 h and was rinsed
afterward with deionized water for 15-20 s. Just prior to
use, the reducing solution was prepared. The reducer
solution consisted of two solutions: Reducer Aldehyde, made
of 11 ml of reducer aldehyde concentrate diluted in 71.5 ml
of deionized water, and Reducer Base, prepared by diluting
11.0 ml of reducer base in 72.5 mis of deionized water.
The reducer solution was poured onto the gel and the gel
shaken for 10 min. After decanting the first reducer bath,
fresh reducer solution was added and the protein bands
allowed to develop until the desired intensity was reached.
To stop development, a Stabilizer Base Solution (20 ml of
stabilizer Base concentrate plus 880 ml deionized water) was
added to the gel; a fresh solution of stabilizer base was
added after 10-15 min. Gels were stored in the last
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stabilizer solution or wrapped in Saran Wrap and sealed in a
Zip-loc bag.
KODAVUE STAINING PROCEDURE
Kodavue (nickle stain) kits purchased from Eastman
Kodak Company, Rochester, New York were employed for
staining 1-D slab gels. Polyacrylamide gels were fixed
overnight in methanol-acetic acid (50% - 5%) (v/v) solution.
Gels were then transferred to a second methanol-water (50% -
50%) (V/V) solution for 1 h. After fixing, the gel was
washed in deionized water for a minimum of 1 h, and the
water changed 2-3 times during this procedure. The water
was decanted and the presensitizer (50 ml of kodavue
presensitizer concentrate in 200 ml water) working solution
was poured onto the gel and shaken gently for 1 min.
Presensitizer solution was then removed and the gel treated
with fresh solution a second time for 1 min. This latter
solution was decanted and sensitizer solution added (25 ml
of kodavue sensitizer concentrate in 225 ml water) for 1
min. This solution was replaced with water, and the gel was
washed in several (3-4) changes for 30 min. While washing
the gel, the developing solution (20 ml of Developer B, plus
entire contents of Kodavue Reducing Agent and 60 ml of
Kodavue Developer Part A, diluted in 120 ml of water) was
prepared and cooled by placing it at -20°C for 5 to 10
min. At the end of the washing step, the developing
solution was added to the gel for 1 min. The solution was
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discarded and fresh developing solution was added. Gels
were shaken gently until protein bands were visible.
Periodically, gels were inverted to avoid entrapment of
gases, which prevented cracking of gels. Development was
terminated by addition of stabilizing solution (4 ml of 1-
Phenyl-lH-tetrazole-5-thiol to 200 ml water). Gels were
stored indefinitely in the stabilizer solution or sealed in
plastic bags after overnight immersion in the stabilizer
solution.
SAMPLE PREPARATION FOR ELECTRON MICROSCOPY
Scanning Electron Microscopy. Red blood cells and
membranes were fixed for 12 h by adding 1 volume of 4%
glutaraldehyde in 5PN(8) to 1 volume of sample. Samples
were washed one to two times for 15 min in deionized water,
and dehydrated through a graduated series of ethanol.
Samples were then air dried or critical point dried using
liquid carbon dioxide and subsequently coated with platinum.
They were viewed with an ETEC Omniscan Scanning Microscope.
Transmission Electron Microscopy. Membranes were
prepared according to the procedure of Fairbanks et al.
(1971). Early attempts to examine membrane skeletons were
unfruitful because upon centrifugation, skeletons become
tightly packed and flattened. Recent developments in
procedures by Shen et al. (1985) have permitted
visualization of individual skeletons in some detail. The
new procedure employs sucrose gradients to isolate
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unflattened skeletons. After extraction, a suspension of
skeletons was layered on a sucrose step gradient (10-30%) in
5PN(8). A 60% cushion was used to prevent pelleting. The
total volume was 31 ml with 7 ml of the 10-30% sucrose
gradient and 10 ml of the 60%. Three ml of the suspended
skeletons was layered on the gradient and the tubes were
placed in a Beckman SW 25.1 swinging bucket rotor. The rotor
was spun in a Beckman L5-50 ultracentifuge at a speed of
90,000 X g (24,000rpm) at 4°C for 30 min. After
centrifugation, the skeletons were located at the 10-30%
sucrose interface. Skeletons were collected from the
interface with a pasteur pipet and placed in dialysis
tubing, where they were dialyzed overnight against 5PN(8)
containing 0.1 mM dithiothreitol. A droplet of sample was
placed on formvar carbon coated grids (200 mesh)
(International Scientific Microscopy Co.) and was allowed to
stand for 30 s. Residual solution from the droplet was
absorbed with Whatman filter paper. Grids were washed for
60 s with a continuous slow stream of deionized water, and
samples then stained with a filtered 2% uranyl acetate
solution. This step was repeated a second time and the
residual stain was removed as above. Grids were then
allowed to air dry in a dust free area. Samples were viewed
with a Hatachi Transmission Electron Microscope and
photographed using Polaroid film.
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Photography. Gels were photographed with a Polaroid
525 Land Camera with type 52, 55 or 655 black and white or
color Polaroid film. In some cases, a 35mm Nikon camera
with 135 Kodachrome film was used. A yellow filter was used
to enhance contrast in black and white photographs of
coomassie blue stained gels.
Chapter IV
Experimental Results
Ultrastructure of Skeletons from Sickle and Normal
Erythrocytes
In order to confirm whether skeletons prepared in this
study were intact and exhibited the ultrastructure and
morphology of skeletons previously described, skeletons were
examined with the transmission electron microscope according
to the procedure of Shen et al. (1965). Previous attempts
to visualize the membrane skeleton with the electron
microscope were difficult, because aggregation of skeletons
occured upon pelleting. One of the benefits of Shen's
procedure is that it provides a method of collecting
skeletons without pelleting.
Skeletons prepared in this study are shown in figure 6.
All of these skeletons appear intact as indicated by the
continous interconnections and distribution of filamentous
material.
At higher magnification, the skeletons appear to be
composed of filamentous structures (Fig. 7). The
filamentous network appears to be composed of repeating
units of connecting hexagonals, as previously reported by
others (Branton et al., 1985).
Lux et al. (1971) previously reported that membrane
skeletons prepared from normal erythrocytes retained the
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Fig. 6. Transmission electron micrographs of negatively
stained normal (a) and sickle (b) erythrocyte
membrane skeletons. Erythrocyte membranes were
extracted with 2 volumes of 4% Triton X-100 in
Hepes-Ringers Buffer [6 M KCl, 48 mM Hepes/Ringer
(pH 7.4), 1.0 mM MgCl2, 0.05 mM CaCl2 and 0.4 mM
DFP] on ice for 30 minutes. The skeleton mixture
was layered on a density step gradient consisting
of 7 ml each of 10%, 20%, 30% and 10 ml of 60%
sucrose (wt/wt) in 1.5 M NaCl • 5 mM NaPi (pH
7.0), and spun at 24,000 rpm for 30 minutes in a
Beckman SW 25.1 rotor. The skeletons were
collected from the 30%/60% sucrose interface and
were dialyzed overnight at 4°C against 2 mM NaPi
(pH 7.0). Skeletons were fixed and stained with
1% uranyl acetate and subsequently viewed with the
Hatachi transmission electron microscope.
Magnification = x7000.
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Fig. 7. Transmission electron micrograph of a membrane
skeleton prepared from a sickled erythrocyte and
viewed at high magnification (x70,000) . The
circular material depicted by arrows are
presumably spectrin molecules . Skeleton were
prepared as described in the legend Figure 6.
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normal shape, while skeletons prepared from irreversible
sickle cells, retained the characteristic sickle shape. In
order to establish that ISC skeletons in these experiments
retained the shape of irreversible sickle cells, skeletons
were isolated from an enriched population of ISCs. The
appearance of an ISC enriched fraction is shown in Figure 8-
b. Typically 70% of the cells in this fraction have a
sickle shape. A control preparation of normal erythrocytes
is shown in panel 8-a.
Skeletons prepared from this fraction can be seen in
Figure 9. Some skeletons have a sickle shape, while others
have a normal shape. Analysis of several fields indicates
that the percentage of sickled skeletons is significantly
less than the percentage of sickled cells. To determine
whether this discrepancy was due to the loss of ISC
skeletons upon preparation, ISC membranes were also
examined. Analysis of membranes indicates that all ISC
membranes do not retain the shape characteristic of ISCs,
although normal membranes do (Figs. 10-b and 11-b). This
observation suggests that the reduction in ISC skeletons is
not an artifact of skeleton preparation, but rather that all
sickled cells in the ISC-enriched preparation are not ISCs
or that some ISC membranes are not permanently deformed.
Some membranes do retain the sickle shape and these are
presumable membranes which give rise to sickled skeletons
(Pig. 11).
Fig. 8. Scanning electron micrographs (SEM) of normal
(a) and ISC enriched irreversibly sickle (b)
erythrocytes. Red cells were collected from the
bottom fraction of a dextran density gradient
(24-34%) and were processed for viewing as
described in materials and methods.
Magnification = xl,630.
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Fig. 9. Transmission electron micrograph of membrane
skeletons prepared from sickle erythrocytes.
Skeletons shown here are elongated, typical of
the sickled shaped ISC in figure 8. Skeletons
were prepared as described in the legend to
Figure 6. Magnification = x3100.
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Fig. 10. Transmission electron micrographs of negatively
stained normal (a) and sickle (b) membranes.
Erythrocyte membranes were pared according to
Fairbanks et al. (1971). A drop of membrane
suspension (0.4 mg protein/ml) was spread on a
formvar-carbon coated grid, excess membrane
suspension was drained by capillarity and the
grid was immediately stained with two (2) drops
of aqueous 1% uranyl acetate for 30 seconds.
The grid was washed immediately with a
continuous stream of deionized water and
subsequently air dried in a dust free area.
Magnification = 4700.
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Pig. 11. Transmission electron micrographs of negative ly
stained normal (a) and sickle (b) membranes.
Samples were processed as in the legend to
Figure 6. Magnification = x7000.
54
55
Characterization of the Protein Composition of Sickle
and Normal Membranes by One-Dimensional SDS- Gel
Analysis
To detect possible differences in sickle membrane
skeletal proteins, skeletons were extracted from normal and
sickle erythrocytes, solubilized under denaturing conditions
(with dithiothreitol - DTT) and subsequently examined on
Laemmli SDS-polyacrylaraide gradient gels (5-15%). The
Laemmli gel system has greater resolving power than the
Fairbanks gel system, which was used in previous studies
(Lux et al., 1979; Riggs and Ingram, 1977). Unlike the
Fairbanks system, the Laemmli system is capable of
fractionating protein band 4.1 into two bands, 4.1 a and 4.1
b. To further improve the resolving power of the Laemmli
gel, sucrose, which stabilizes the acrylamide gradient, was
added to the gel solution. Separation of skeletal proteins
on these gels was improved compared to gels without sucrose.
All of the major proteins in membrane skeletons can be
identified when fractionated on Laemmli gels and
subsequently stained with coomassie blue (Fig. 12, lanes 3
and 4). The nomenclature of Fairbanks et al. (1971) has
been adopted to identify the respective proteins (bands).
Bands 1 and 2; bands 4.1 a and 4.1 b; band 4.9; and band 5.
In comparison to whole membranes (Fig. 12, lanes 1 and 2),
Fig. 12. SDS-polyacrylaraide gradient (Laemmli, 5-15%) gel
of reduced (DTT) membrane and membrane skeletal
proteins. Gels were stained with coomassie
blue. Fifty ug of membrane proteins were
applied to each lane. Lane: 1) Normal
Membranes; 2) Sickle Membranes; 3) Normal
Skeletons; and 4) Sickle Skeletons. Protein
bands are numbered according to the nomenclature










the membrane skeleton protein profile represents, as
expected, a subset of the membrane proteins.
Comparison of the protein composition of normal and
sickle skeletons, after staining gels with coomassie blue,
revealed one major protein difference. It was observed that
sickle 4.1 a and b were altered quantitatively compared to
their analogues in normal skeletons. In normal skeletons,
the amount of protein 4.1 a is greater than 4.1 b. However,
in sickle skeletons the reverse is true. No other
differences were observed between skeletal protein profiles
visualized after staining with coomassie blue.
In order to increase the probability of detecting
differences between sickle and normal membrane skeletons,
additional protein stains possessing varying specificities
were employed. Included among these stains are several
recently developed silver staining procedures: 1) Tsang et
al., 1984; 2) Bio Rad (modified procedure of Merrill et al.,
1981); and 3) Gelcode (Upjohn Diagnostic). Although these
procedures vary somewhat, the chemical basis for protein
staining is the same. Color development is due to the
formation of silver ion complexes with charged amino acid
side chains. It has been reported that the silver stains
are 50-100 times more sensitive than coomassie blue (Merrill
et al., 1981; Oakley et al., 1980), and comparable in
sensitivity to autoradiography of [S^^] methionine labeled
proteins (Sammons et al., 1981).
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Figure 13 shows the protein pattern of membrane
skeletons and membranes on an SDS gel stained with the
silver procedure of Tsang et al. (1984). The colors of both
membrane and skeletal proteins range from various hues of
brown (e.g., band 3), orange (e.g., region 4.5), and blue
(e.g., spectrin). It is evident, when these gels are
compared to gels stained with coomassie blue, that the Tsang
silver staining procedure is far more sensitive. A greater
number of low molecular weight (Imw) bands can be seen in
these gels in both whole membranes and membrane skeletons.
The staining sensitivity of silver over coomassie blue is
best demonstrated in the high molecular weight region
between bands 2 and 4.1 and in the lower molecular weight
region of 4.5. The relative staining intensities of these
bands are increased several fold compared to the coomassie
blue profile. The globin band can be clearly seen in these
gels but not in gels stained with coomassie blue, further
indicative of the greater sensitivity of the silver stain.
As in gels stained with coomassie blue, the protein
profile of normal and sickle skeletal proteins on silver
(Tsang et al., 1984) stained gels are very similar. But the
4.1 a and b alteration is evident and in addition, a
difference is observed in two minor proteins which migrate
slightly slower than band 4.1. These proteins have been
tentatively named 4.0 a and 4.0 b. The 4.0 a band in normal
skeletons is stained more intensely than 4.0 b, similar to
Fig. 13. SDS-polyacrylamide gradient (Laemmli, 5-15%) gel
of reduced (DTT) membrane and membrane skeletal
proteins. Gels were stained with silver (Tsang
et al., 1984). Fifty ug of membrane proteins
were applied to each lane. Lane: 1) Normal
Membranes; 2) Sickle Membranes; 3) Normal
Skeletons; and 4) Sickle Skeletons. Asterisks
depict the doublet undetected in coomassie blue
stained gels. Protein bands are numbered




the relationship between 4.1 a and b in normal skeletons#
while the staining intensities of sickle skeleton 4.0 a and
b are reversed, and are similar to the relationship of
sickle skeletal band 4.1 a to b. High molecular weight
proteins (above band 1) are present in both skeletal
preparations, however, no difference was detected within
this region. The hmw proteins are also detected in normal
and sickle membrane preparations. Essentially, all of the
hmw material detected in membranes can be accounted for in
skeletons and thus can be considered skeleton associated
material. Although no additional differences could be
detected with silver (Tsang et al., 1984), the fact that a
greater number of bands are seen in both normal and sickle
skeleton profiles, including the hmw material, indicates
that the skeleton is more complex than that revealed by
staining with coomassie blue.
A second silver stain, manufactured by Bio Rad
Scientific Products (modified procedure of Merrill et al.,
1981), was also used to stain gels on which membrane
skeletal proteins had been electrophoretically fractionated.
Like the procedure of Tsang et al. (1984), this procedure,
too, appeared more sensitive than coomassie blue (Fig. 14).
In fact, it appeared more sensitive than the Tsang
procedure. Unique to this method is the absence of staining
of bands 1 and 2 (spectrin), 2.1 (ankyrin) and band 4.9.
The opaqueness and lack of staining of these bands may be
Fig. 14. SDS-polyacrylamide gradient (Laenunli, 5-15%) gel
of reduced (DTT) membrane and membrane skeletal
proteins. Gels were stained with silver (Bio
Rad). Fifty ug of membrane proteins were
applied to each lane. Lane: 1) Normal
Membranes; 2) Sickle Membranes; 3) Normal
Skeletons; and 4) Sickle Skeletons. Asterisks
depict the doublet undetected in coomassie blue
stained gels. Protein bands are numbered
according to the nomenclature of Fairbanks et
al. (1971).
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Fig. 15. SDS-polyacrylamide gradient (Laemmli, 5-15%) gel
of reduced (DTT) membrane and membrane skeletal
proteins. Gels were stained with gelcode
(Upjohn Diagnostic). Fifty ug of membrane
proteins were applied to each lane. Lane: 1)
Normal Membranes; 2) Sickle Membranes; 3) Normal
Skeletons; and 4) Sickle Skeletons. Asterisks
depict the doublet undetected in coomassie blue
stained gels. Protein bands are numbered
according to the nomenclature of Fairbanks et
al. (1971).
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Fig. 16. SDS-polyacrylamide gradient (Laemmli, 5-15%) gel
of reduced (DTT) membrane and membrane skeletal
proteins. Gels were stained with nickel
(Kodak). Fifty ug of membrane proteins were
applied to each lane. Lane; 1) Normal
Membranes; 2) Sickle Membranes; 3) Normal
Skeletons; and 4) Sickle Skeletons. Asterisks
depict the doublet undetected in coomassie blue
stained gels. Protein bands are numbered





However, the inability to observe the 4.1 alteration in
these gels seems to be due to diffusion. This may be due to
the nonlinear formation of a gradient in the 4.1 region,
thus preventing the complete stacking of the protein band.
In summary, analysis of sickle skeleton proteins,
employing an improved Laemmli gels system in conjunction
with various sensitive protein stains have revealed the
following; 1) Skeletal proteins 4.1 a and 4.1 b are altered
quantitatively; 2) Skeletal proteins 4.0 a and 4.0 b are
also altered quantitatively, similarly to protein 4.1; 3)
high molecular weight complexes are apparent when normal and
sickle membranes are stained with the Tsang et al., silver
staining method (1984), and this hmw material seems to be a
component of the membrane skeleton; 4) membrane skeleton
protein profiles in gels stained with silver (Tsang et al.,
1984; and Bio Rad) and Gelcode are more complex than in gels
stained with coomassie blue. The common opaque appearance
of certain skeletal proteins when gels were stained with the
Bio Rad silver method may be beneficial in establishing
protein relationships as indicated by similar color (i.e.,
spectrin and band 4.9).
Characterization of the Protein Composition of Membrane
Skeletons on Isoelectric Focusing (lEF) and Two-
Dimensional Gels (lEF/SDS-PAGE)
SDS-polyacrylamide gel electrophoresis, the technique
used in the preceding studies, fractionates proteins on the
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basis of size. Isoelectric focusing is another analytical
tool that is extremely useful for fractionating protein
species from complex mixtures based on net charge. The
technique fractionates the proteins over a pH gradient
established by ampholytes (charged synthetic amino acids) in
an acrylamide support medium. Utilization of combined
ampholytes with a pH range of 3.5-10/ 5-7 and 6-8# generated
a pH gradient ranging from 3.5 to 7.5 (Pig. 17). A pH
gradient of 3-7 was established consistently when the above
ampholytes were employed.
Skeletal proteins demonstrated a broad range of pIS/
spanning the upper limits of the cathode (alkaline) end to
the mid-lower region of the anode (acid) end. The number of
skeletal proteins fractionated on lEF gels is comparable to
the number of protein bands fractionated on 1-D SDS gels.
In order to identify the skeletal proteins on lEF gels
and to determine their pis, individual proteins bands were
excised from SDS-gels and subjected to isoelectric focusing.
Band 1 (Spectrin alpha subunit) focused with a pi of 4.2-5.3
(Pig. 17, lane 3). Band 2 (Spectrin beta subunit) was
located in two pi regions. The predominate species Sp-2'
migrated with a pi of approximately 7.2, whereas the minor
component designated Sp-2', exhibited a pi of 5.2 (Fig. 17,
lane 4). That band 2 yields polypeptides with two distinct
pis was further supported by two-dimensional gel analysis.
In the band 2 region, two distinct spots are seen with
Fig. 17. Isoelectric focusing gels of solubilized (Urea +
NP-40) normal and sickle membrane skeletons and
purified membrane skeletal proteins. Protein
bands were excised from gels, to which 50 ug of
proteins had been applied, and then applied to
the origin of an isofocus gel. Gel; 1) Normal
Skeletons; 2) Sickle Skeletons; 3) Purified band
1; 4) Purified band 2; 5) Purified band 4.1; 6)
Purified band 5. The pH profile extended from
3.5 to 7.4. The pH scale represents 1 pH unit
per 10 cm, reading from the anode end (bottom of
gel) to the cathode end (top of gel). The
apparent staining in gel 5 is artifactual.
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differing pis (Fig. 18). Band 5 (Actin), focused with a pi
of 4.3. Attempts to isolate protein 4.1 from SDS gels
yielded only traces of the protein which were not detected
when the protein was subjected to electrophoresis on lEF
gels. However, the position of protein 4.1 in an isofocus
gel was inferred based on its localization in two-
dimensional gels. In these latter gels, the protein
migrated as a broad band at a pH comparable to Sp-2'.
The combined analysis of isolated skeletal proteins in
the first dimension gel and skeletal proteins in the second
dimension gel permitted an accurate identification of the
proteins in each lEF band. In Figure 19, the bands in the
skeletal preparation are labeled based on these studies.
Although it was thought that lEF gels would be more
resolving in detecting protein differences in sickle
skeletons, the lEF profile of sickle skeletal proteins was
indistinguishable when compared to normal (Fig. 16, lane 2).
The apparent differences in profile seen in the pH 5.5 and
4.5 regions are not reproducible. Similarly, two-
dimensional patterns of normal and sickle skeletons were
identical (Fig. 18).
Studies on the Organization of Sickle and Normal
Membrane Skeleton Proteins with Crosslinkinq Reagents
In the preceding studies, techniques were employed to
assess the composition of normal and sickle skeletons and to
determine whether differences existed between the two
Fig. 18. lEP/SDS-polyacrylamide gels of normal and sickle
membrane proteins. Fifty ug of membrane
skeletal proteins were focused in the first
(lEF) dimension and the gel subsequently sealed
with 1% agarose to the second dimension (SDS-
PAGE). SDS-gels were electrophoresed at 20
mAmps per gel at constant amperage and
electrophoresis was continued until the tracking
dye reached the bottom of the gel. Gels were
subsequently stained with coomassie blue. Gel;
A) Normal membrane skeletons; B) Sickle membrane
skeletons.
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Fig. 19. Normal membrane skeletal proteins identified on









skeletons. To examine whether sickle skeleton proteins
differ in arrangement, several different bifunctional
crosslinking reagents were used. Crosslinking of protein
subunits generates hmw complexes that are greater in size
than the subunits. The rate of movement of a complex in an
SDS gel is directly related to its size. Crosslinking
reagents that were used in this study of skeletal proteins
are: (1) 0-phenanthroline/copper sulfate (0-phe/CuS04); (2)
Dithiobissuccinimidyl propionimidate (DTSP); and (3)
Dimethyl 3, 3 *-dithiobispropionimidate-2-Hydrochloride
(DTBP). Preliminary studies were conducted to determine the
optimal conditions to generate discrete crosslinked
complexes of membrane skeleton proteins.
Membrane skeletons (0.73 mg protein/ml) were reacted
with 0-phe/CuS04 at a final concentration of 0.1 mM for 0,
10, 20, 30 and 60 min (Fig. 20). 0-phe/CuS04 generated 3
distinct crosslinked products. 0-phe 3, the smallest
complex, formed earliest of all the complexes, while
complexes 0-phe 1 and 0-phe 2 became more prominent with
increasing time of reaction. A corresponding reduction in
bands 1 and 2 was observed suggesting that spectrin is a
major component of the complexes. When the reaction was
stopped, 0-phe 3 was the predominate complex in normal
skeletons, whereas 0-phe 2 was the major complex in sickle
skeletal preparations.
Fig. 20. Normal (A) and Sickle (B) membrane skeletons
(0.73 mg protein/ml) reacted with 5 mM O-
phe/CuS04 at the following time periods; Gel:
1) Control; 2) 0 min; 3) 10 min; 4) 20 min; 5)
30 min; and 6) 60 min. Samples were analyzed on
4% Fairbanks tube gels and proteins were
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In an attempt to identify the constituents of the
complexes, two-dimensional diagonal SDS-PAGE was employed.
Gels with distinct and prominent complexes were selected for
two-dimensional diagonal analysis. Diagonal gel
electrophoresis permits separation of the crosslinked
protein in the second dimension. After electrophoresing the
complexes through a reducing (DTT) phase within the 4%
stacking gel, polypeptides that are dissociated by reduction
can be seen as spots occurring off the diagonal. Protein
subunits that are not crosslinked are seen in a skewed
diagonally shaped curve. A schematic illustration of this
procedure is shown in Figure 21.
Control samples (i.e., not treated with crosslinking
reagents) of normal and sickle skeletons electrophoresed on
2-dimensional diagonal gels are shown in figure 22. No
complexes were seen migrating off the skewed diagonally
shaped curve. All of the major components were readily
identified in reference to the control one-dimensional lane.
Analysis of 0-phe crosslinked skeleton protein complexes on
2-D diagonal gels (Fig. 23), showed that 0-phe 1 was
composed of all the major polypeptide components of the
skeleton. 0-phe 2 and 3, however, were composed chiefly of
spectrin bands 1 and 2 and ankyrin.
Skeletons reacted with DTSP (Fig. 24) at a final
concentration of 0.016 mM for 0, 3, 6, 9 and 12 min
generated 3 distinct products. In contrast to complexes
Fig. 21. A schematic diagram of two dimensional diayonal
(SDS-SDS) PAGE. Non-reduced crosslinked
complexes are fractionated on Fairbanks (4%)
cylindrical gels and the gels subsequently
sealed at the top of the second dimension SDS-
polyacrylamide (Laemmli, 5-15%) gel with 1%
aqueous agarose (+ DTT). The crosslinked
complexes are reduced to their individual
polypeptides as they migrate through the
reducing phase. Non-crosslinked polypeptides
(monomers) are depicted on a diagonal curve.
Dimers and Trimers of monomers can also be
determined based on the molecular weight of the
reduced crosslinked product. Homopolymers of a
polypeptide are depicted by asterisks, while
heteropolymers are shown in the vertical axis as
in complexes a, b, and c. The Control lane
serves as a reference marker in order to
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Fig. 22. Two-dimensional (SDS/SDS) diagonal gel of
control Normal (A) and Sickle (B) membrane
skeletons. A solution composed of 0.5 ml of DTT
(0.248 mg/ml), 0.2 ml of Pyronin-y and 1.8 ml
electrophoresis buffer was applied at the
interface of the separating (slab) gel and
allowed to percolate in the gel for 30 minutes.
The first dimension 4% tube (Fairbanks) gel was
then sealed on top of a slab (Laemmli) gel with
1% agarose. Electrophoresis was carried out at
20 mAmps per gel and terminated when the
tracking dye reached the bottom of the gel.
Gels were subsequently stained with coomassie
blue.
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Fig. 23. Diagonal gels of Normal (A) and Sickle (B)
membrane skeletons reacted with 5 mM 0-phe/CuS04
at 60 min. Electrophoretic conditions are





Fig. 24. Normal (A) and Sickle (B) membrane skeletons
reacted with 8 mM DTSP at the following time
periods: Gel: 1) Control; 2) 0 min; 3) 3 min;
4) 6 min; 5) 9 min; and 6) 12 min.
Electrophoretic conditions are described in the
legend of Figure 20.
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formed with 0-phe, the products were formed very rapidly and
the amount of each plateaued as early as 3 min of reaction
time. Concommitantly, a large reduction was noted in the
spectrin band as well as band 4.1. Interestingly, band 4.1
was reduced most dramatically and was crosslinked completely
by 3 min, while only a smaller reduction was seen in band 5.
When sickle skeleton crosslinked products were compared to
normal skeleton crosslinked products, no differences were
noted.
Normal and sickle skeletons reacted with DTSP for 12
min were subjected to 2-dimensional analysis (Pig. 25).
DTSP 1 was composed of all major skeletal proteins while
DTSP 2 and 3 were composed of only spectrin (Fig. 24). A
homopolymer of band 5 was detected in these gels, which was
not apparent in the first dimension gels. Comparison of
sickle versus normal skeletons indicated no differences in
the polypeptide composition of crosslinked products.
Of the three reagents tested, DTBP was least reactive
with membrane skeletons. Skeletons were treated with a
final concentration of 0.3 mg/ml of DTBP at 60, 90, 120 and
150 min. Five crosslinked bands were produced, two of which
are prominent complexes, and three minor ones (Fig. 26).
Bands 4.1 and 5 became more diffuse and exhibited a greater
mean mobility. The reason for this anomalous behavior is
unknown, however, it is conceivable that the crosslinking
reagent formed intramolecular bonds within the
Fig. 25. Diagonal gels of Normal (A) and Sickle (B)
membrane skeletons reacted with 8 mM DTSP at 12
min. Electrophoretic conditions are described
in the legend of Figure 22.
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Fig. 26, Normal (A) and Sickle (B) membrane skeletons
reacted with 0.3 mg/ral DTBP at the following
time periods: Gels: 1) Control; 2) 0 min; 3)
60 min; 4) 90 min; 5) 120 min; 6) 150 min.
Electrophoretic conditions are described in the
legend of Figure 22.
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polypeptides, causing some of the polypeptides in each band
to migrate at a lower than normal position in the gel. DTBP
1, in contrast to the polymers crosslinked by the other
reagents, did not enter the gel and was composed chiefly of
small polypeptides (Fig. 27). These polypeptides are minor
constituents in the 4.5 region. The other crosslinked
products were composed of only spectrin. As was the case
with DTSP, no differences in sickle and normal membrane
skeleton crosslinked products was observed after reaction
with DTBP.
To further assess the organization of proteins in
sickle skeletons, crosslinking studies were performed on
intact erythrocytes. The primary objective was to determine
if differences in skeletal proteins could be detected after
crosslinking proteins in intact cells. This approach
offered the greatest potential of detecting "real"
organizational differences in sickle skeletal proteins,
because analysis would be performed on an unperturbed
system. Crosslinking intact cells proved to be extremely
difficult. Several parameters (time, concentration, and
temperature) were varied in order to maximize the
crosslinking conditions. Despite these various changes,
only traces of crosslinked complexes were formed. In order
to detect the small amount of crosslinked products formed,
high concentrations of crosslinked cell proteins were
applied to the gel, and in some instances, the gels were
Fig. 27. Diagonal gels of Normal (A) and Sickle (B)
membrane skeletons reacted with 0.3 mg/ml DTBP
for 120 min. Electrophoretic conditions are










Stained with silver. Spectrin was the only visible
crosslinked component and no difference was noted between
sickle and normal cells in the amount or composition of
crosslinked products (Fig. 28).
Limited Proteolytic Cleavage with Exogenous Proteases
Exogenous proteases are often utilized in the
elucidation of suprastructural protein organization and the
identification of peptide functions of a given polypeptide.
To investigate possible differences in the organization of
sickle membrane skeletons, skeletons from normal and sickle
erythrocytes were treated with several proteases.
Differences in the organization of oligomeric complexes may
be reflected in the generation of peptide differences and in
the rate at which protein subunits were enzymatically
cleaved.
Normal and sickle skeletons (0.73 mg protein/ml) were
treated with Trypsin (T), Chymotrypsin (C) and Pepsin (P).
An enzyme concentration of 0.001 mg/ml was selected for
digesting membrane skeletons. Higher concentrations proved
to be too extreme to generate peptide intermediates for
comparison. Skeletons were digested at two different time
periods (1 and 3 rain) in order to achieve selective
digestion of proteins and to determine if there was a
differential rate of protein degradation in the two samples.
A large number of proteolytic degradation products were
produced in all cases (Fig. 29). Of the three enzymes.
Fig. 28. Diagonal gels of Normal (A) and Sickle (B) whole
cells crosslinked with 24 mg/ml of DTBP.
Electrophoretic conditions are described in the
legend of Figure 22.
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Fig. 29. Membrane skeletons digested with proteolytic
enzymes at 1 and 3 min time periods. Skeletal
proteins (0.2 mg/ml) were digested with 0.001
mg/ml of enzyme and solubilized immediately in
sample buffer. Lane: 1) untreated normal
skeletons; 2) untreated sickle skeletons; 3)
normal and 4) sickle skeletons treated with
trypsin for 1 min; 5) normal and 6) sickle
skeletons treated with trypsin for 3 min; 7)
normal and 8) sickle skeletons treated with
chymotrypsin for 1 min; 9) normal and 10) sickle
skeletons treated with chymotrypsin for 3 min;
11) normal and 12) sickle skeletons treated with
pepsin for 1 min; 13) normal and 14) sickle
skeletons treated with pepsin for 3 min.
Skeletons were analyzed on Laemmli SDS-
polyacrylamide gradient gels after staining with
silver (Tsang et al., 1984).
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trypsin and chymotrypsin were more effective than pepsin.
Spectrin and protein 4.1 were far more sensitive to
proteases than band 5. This latter protein was hardly
degraded with chymotrypsin and pepsin. When sickle
skeletons were compared to normal, sickle spectrin seemed to
be digested faster after treatment with trypsin and
chymotrypsin. Although several other minor differences were
noted (see arrows) between sickle and normal skeletal
profiles after trypsin and chymotrypsin treatment, these
differences are probably not significant.
CHAPTER V
DISCUSSION
The primary objective of this study was to search for
protein alterations in sickle cell membrane skeletons. To
determine whether there are differences in the composition
and organization of normal and sickle skeletal proteins, a
comprehensive approach employing several biochemical
techniques for characterizing proteins was utilized.
Since the discovery of sickle hemoglobin and its
abnormal behavior under oxygenated and deoxygenated
conditions, several alterations in the membrane of sickle
cell have been characterized, including an abnormal shape,
deformability and adhesivity. All of these cellular
alterations are presumably acquired defects within the
membrane resulting from sickling. Each of these properties
is controlled to a large extent by the proteinaceous
membrane skeleton, as indicated by studies of hemolytic
anemias, in which a protein in the cell skeleton is
defective. The most striking evidence suggesting that the
membrane skeleton of sickle erythrocytes is altered was
reported by Lux et al. (1971). It was demonstrated that
skeletons extracted from irreversible sickled cells (ISCs)
retained the shape characteristic of the cell. Evidence
linking altered deformability and adhesivity with a
defective skeleton is not as convincing, however, it was
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shown that the specific aggregation of spectrin molecules
leads to changes in the distribution of negatively charged
sites on the external surface of the cell (Nicholson and
Painter, 1972). These changes are thought to give rise to
the increased membrane adhesivity characteristic of sickle
cells (Hebbel et al., 1980). It has been established that
the cell's ability to be deformed is due to the membrane
skeleton (Lange et al., 1982), implying that the abnormal
deformability of sickle membranes is caused by a defective
skeleton. It is, thus, conceivable that a single protein
defect in the membrane skeleton may account for all of the
cellular alterations in sickle cells discussed above; but
defects in sickle erythrocyte skeleton proteins have not yet
been defined at the molecular level.
In this study, several observations were made in the
comparative analysis of normal and sickle skeletons; (a)
sickle skeleton proteins 4.0 and 4.1 are altered
quantitatively; (b) several quantitative differences were
detected between crosslinking agent-induced protein
complexes of normal and sickle skeleton proteins; (c)
several quantitative differences were detected in the
peptide maps of sickle skeletons; (d) no differences were
detected in the two types of skeletons after isoelectric
focusing or two dimensional gel electrophoresis (lEF/SDS-
PAGE); (e) the ultrastructural appearance of sickle
skeletons was comparable to that of normal ones.
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Before examining the protein composition and
organization of sickle skeletons, it was essential to
establish whether the skeletons prepared from normal and
sickled erythrocytes were intact and exhibited the
appropriate ultrastructure and morphology. Earlier attempts
(C. Floyd, 1983) to view erythrocyte skeletons by scanning
electron microcropy (SEM) were unsuccessful, because
skeletons aggregated during centrifugation after the
dehydration and fixation steps. The skeletons appeared as a
confluent layer of flattened skeletons, which prevented
their ultrastructural analysis. The skeletons whose
electron micrographs are presented in this study were
prepared according to the procedure of Shen et al. (1985).
Shen's procedure utilizes a density gradient in order to
collect non-sedimented skeletons. In the previous study,
skeletons were fixed with glutaraldehyde and viewed with the
scanning electron microscope, whereas membrane skeletons in
this study were negatively stained with uranyl acetate and
viewed with the transmission electron microscope. These
modifications vastly improved the visualization of
erythrocyte membrane skeletons.
The ultrastructure of the skeletons prepared in this
study is similar to that previously reported by others (Lux
et al., 1971; Yu et al., 1973; Shen et al., 1985). They
appear as dense reticula of filamentous material. The
circular filamentous material seen in the skeleton is
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presumably spectrin and appears analogous to the repeating
units seen in Shen's skeleton preparations. The ultra¬
structure appearance of the filamentous meshwork of sickle
and normal skeletons was similar. To enhance the
visualization of skeletal components with the EM, Shen
artificially expanded the spectrin network by extracting
skeletons with DTT in the extraction buffer. Similar
attempts in this study yielded only dense undilated
reticula.
Skeletons extracted from normal erythrocytes appear to
have a similar shape as normal cells, while some skeletons
prepared from sickled cells, possessed the sickled shape,
similar to the observations of Lux et al. (1976).
One approach to determining whether alterations exist
in the polypeptides of sickle membrane skeletons is to
fractionate the skeletal proteins by electrophoresis on SDS
polyacrylamide gels and compare the protein profile to that
of normal. It is conceivable that sickle skeletons would
exhibit a loss or gain of proteins and/or quantitative
protein differences. In previous studies, no differences in
the protein composition of normal and sickle skeletons were
detected (Lux et al., 1976). Since that study, the
resolving capacity of electrophoretic systems has greatly
improved. The tris-glycine gel (Laemmli, 1971) system has
greater resolving power than the Fairbanks (1971) gel system
used by Lux et al. (1976), and therefore, is more frequently
91
used to fractionate proteins. Th separation of complex
proteins is further resolved on Laemmli gels when sucrose is
added to the gel solution. In this study, the gel system of
Laemmli, with the addition of sucrose, was routinely
utilized for the separation of sickle and normal skeletal
proteins.
In order to further resolve protein differences between
normal and sickle skeletons, Laemmli gels were stained with
several protein stains proven to be more sensitive than the
conventionally used coomassie blue. Use of these stains:
silver (Tsang et al., 1984; modified Merrill et al., 1981)
and Gelcode in this study has led to the detection of
several skeletal proteins which had not been previously
observed when gels were stained with coomassie blue. Gels
stained with both Tsang and Bio-Rad silver methods revealed
HMW material in membranes and membrane skeletons. In
addition, a doublet band migrating in the tail region of
band 3 and several low molecular weight proteins were
detected in normal and sickle skeletons. Detection of these
high and low molecular weight proteins in skeletons suggests
that the red cell membrane skeleton is more complex than
previously thought. These unidentified proteins are
considered legitimate skeletal associated proteins, since
precautions were taken to avoid protein artifacts. Their
characterization should enhance our understanding of
membrane skeleton structure and function.
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Analysis of sickle skeletal proteins separated on
Laemmli gels revealed four differences when compared to
proteins from normal skeletons. Two alterations were
detected in a protein doublet, which migrated in the band
4.1 region. The protein doublet was designated 4.0a and
4.0b and was only detected by silver stains. Protein 4.0a
is increased in the normal relative to the sickle, while
4.0b is decreased. Although the molecular weights of these
proteins have not been determined, it is possible that these
proteins are the 4.1 related bands identified by Cohen et
al. (1982), having a molecular weight of approximately 85
kd. Additionally, several isoforms of the 4.1 protein have
been identified in a variety of nonerythroid cells (see 4.1
section in the review of literature) by immunocrossreactive
studies which exhibit a broad range in molecular weights
(i.e., 67-150 kd). Similar approaches used to identify the
4.1 isoforms could also be employed in determining the
nature of the 4.0 proteins.
Two additional alterations were detected in sickle
proteins 4.1a and 4.1b. The 4.1a and 4.1b are sequence-
related phosphoproteins, as indicated by their similar 32p_
labeled peptide maps (Goodman et al., 1982). The 4.1a and b
alterations were detected with coomassie blue and with
several silver stains which were used. It is interesting to
note that the 4.1 alteration is remarkably similar to the
alterations noted in 4.0. Like protein 4.0b, the 4.1b
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protein is also increased in sickle skeletons when compared
to normal skeletal protein 4.1b, while protein 4.1a is
decreased. The close similarity in their profiles suggest
their relatedness, and the evidence provided below as a
possible mechanism for the 4.1a and b alterations, could
certainly account for the alterations in the 4.0 proteins.
However, additional studies are warranted to understand
these alterations in sickle skeletons.
The mechanism responsible for the alterations in the
4.0 and 4.1 proteins is not proteolysis, since proteolytic
inhibitors are routinely employed in all extraction buffers.
Several studies suggest that protein 4.1b is converted to
4.1a during the aging of red blood cells in the circulation.
Sauberman et al. (1979) showed that the amount of protein
4.1b was increased and 4.1a decreased in red blood cells
from individuals with hemolytic anemias. These individuals
characteristically have relatively young erythrocytes.
Yaddanapudi et al. (1987) showed that red cell membranes
from patients with transient erythroblastopenia of childhood
(TEC), a disease in which erythroid cell production is
temporarily ceased, contain greater amounts of 4.1a than
4.1b; however, when erythropoiesis is normalized, the amount
of 4.1b is increased, while 4.1a shows a concomitant
decrease. Similar findings showing the age dependence of
the amount of 4.1a and b proteins was demonstrated in mice
by Mueller et al. (1987). Since sickle cells are relatively
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young cells, it is possible that the above mechanism
explains the 4.1 alteration characteristic of these cells.
This same mechanism may also account for the alteration in
protein 4.0. Yet, preliminary work (P. Floyd, 1987)
suggests that the relative youth of sickle cell erythrocytes
is not the explanation for the increase in protein 4.1b.
O'Farrell's (1975) two-dimensional gel electrophoretic
system has greater resolving power than Laemmli's one¬
dimensional gel system, yet no additional protein
differences were detected in sickle skeletons with this gel
system. However, because of the many complications one
encounters in separating membrane proteins on two-
dimensional gels (O'Farrell, 1975), it is possible that the
two-dimensional gel is not at its limit of resolution, and
can be further perfected for the separation of membrane
proteins. Possibly, with the development of new solubiliza¬
tion agents and broader pH ampholytes, greater resolution of
membrane proteins will be achieved on two-dimensional gels.
While no differences were detected between sickle and normal
skeletons, the isoelectric focusing and two-dimensional gel
analyses reported here represent the most detailed and
comprehensive study reported to date.
An interesting observation made in the isoelectric
focusing analysis was that isolated band 2, the beta subunit
of spectrin, yielded two separate bands focusing at two
different pis. This heterogeneity of the band 2
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polypeptides is frequently observed in non-erythroid cells,
while band 1, the alpha subunit is very similar in all
spectrin molecules that have been studied. Because of the
band 2 heterogeneity in other cell types, it is reasonable
to assume that the lEF profile of band 2 is real.
To determine whether there were differences in the
organization of sickle skeletal proteins, crosslinking
reagents and exogenous proteases were used. It is
reasonable to assume that the abnormal shape of the ISC
membrane skeleton and the rigidity of all sickle membrane
skeleton is due to a change in the arrangement of membrane
skeletal proteins (Palek and Liu, 1979; Rubin, 1980).
Crosslinking reagents have been used extensively as probes
to decipher supramolecular structure and the quaternary
structure of membrane proteins (Steck, 1972; Luther et al.,
1974). While electron microscopy freeze fracture methods
are useful in determining the overall protein distribution
in the plane of a membrane, the resolution for interpreting
individual peptide chains and their disposition is limited.
The problem of detailed arrangement of peptides in membranes
requires techniques of higher resolution. Chemical cross-
linking reagents for nearest neighbor analysis provide such
techniques. Davies and Stark (1970), utilizing crosslinking
reagents, have demonstrated the positioning of parts of
separate polypeptide chains within a distance of 5 to 15
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angstroms (A) of each other. Additional information as to
the stoichiometry of oligomers was also obtained.
Two of the major problems in analyzing neighbor
proteins in cell membranes are (1) the multitude of proteins
within a membrane and (2) the necessity to distinguish
between random interactions, due to diffusion, from real
macromolecular complexes. For these studies, the first
problem is of no consequence since the red cell membrane
skeleton has a relatively simple protein composition.
Because the membrane skeleton is relatively rigid, the
latter problem is avoided. To prevent crosslinking of
proteins located in two different skeletons, low concentra¬
tions of membrane skeletons (i.e., 0.73 mg protein/ml) were
utilized.
In the crosslinking studies reported here, several
quantitative differences were detected in the crosslinked
products of sickle membrane skeletons. Though normal and
sickle skeletons contained three major complexes when
reacted with the reagent 0-phe, the rate of formation of the
complexes varied in the two types of skeletons. In normal
skeletons, 0-phe 3 was the predominate complex, whereas in
sickle skeletons, 0-phe 2 predominated. Analysis of the
constituents of the 0-phe 2 and 0-phe 3 complexes on
diagonal gels revealed that each is composed of bands 1 and
2. 0-phe 2 is a larger oligomer of spectrin than 0-phe 3.
That the higher oligomer is formed more readily in sickle
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skeletons than in normal ones, suggests that spectrin
molecules are more closely associated in sickle membrane
skeletons than in normal and thus are more easily
crosslinked.
While quantitative differences in crosslinked products
were detected with 0-phe, no differences were detected with
the other two crosslinking reagents used in this study-DTSP
and DTBP. Since the capacity of a crosslinking reagent to
link two different proteins depends on the accessibility of
the appropriate groups in the proteins, reagents with
different chemical group specificities react differently
with proteins. This may explain the difference in
reactivity of the reagents used in this study. DTSP and
DTBP are imidoesters and react with amino groups, whereas
0-phe simply catalyzes the oxidation of sulfhydryl groups,
resulting in disulfide bond formation.
Chemical crosslinking of intact cells yielded poor
results; however, this approach is potentially the most
useful method in detecting differences in the organization
of proteins in sickle skeletons. These studies should be
further investigated, utilizing nonpenetrable reagents along
with the agents used in this study, which are permeable.
Since the red cell represents an unperturbed system, it
would lend itself to a more accurate analysis of the
disposition of sickle skeleton proteins.
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The second approach used to assess organizational
differences in sickle skeletons employed exogenous porteases
with different active site specificities. Proteases are
commonly utilized to determine the protein topography,
structural conformation and functional subunits. For
example, Anderson and Jorgenson (1985) were able to
demonstrate the existence of two major conformational states
of the Ca^'''-ATPase enzyme by tryptic and chymotryptic
digestion.
Spectrin was digested faster in the sickle skeletons
than in normal ones. This suggests that spectrin in sickle
skeletons is arranged perhaps in an elongated rather than a
globular state, thus, making the cleavage sites more
accessible to the enzymes. This arrangement of sickle
spectrin may account for the abnormal deformability seen in
sickle cells.
It seems apparent that new approaches must be employed
in order to detect defects in sickle membrane skeletons.
Studies by Platt et al. (1982) employing binding techniques,
demonstrated that normal spectrin bind inefficiently to
protein 2.1 of inside out vesicles prepared from sickle red
blood cells. Similar techniques should be employed to
determine whether the skeletal constituents have defective
associations among themselves and whether or not these
associations contribute to membranes abnormalities. It is
conceivable that defects may exist with in skeletal protein
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(spectrin-4.1-actin) lateral interactions which might be
responsible for the reduced deformability and the abnormal
shape in sickle cells. On the other hand, defects in
vertical interactions between skeletal proteins and the
membrane bilayer (e.g., between spectrin and band 3) may
contribute to the surface alterations which are responsible
for the increased adhesivity of sickle cells.
Further understanding of the defects in sickle protein
skeletons and of the crosslinked complexes should prove
beneficial in developing a therapeutic regime for the




Several conclusions were reached based on the data
obtained in this study:
1. Proteins designated 4.0 a and b are altered
quantitatively in sickle skeletons.
2. Proteins designated 4.1 a and b in sickle skeletons
are altered quantitatively, similarly to sickle
skeletal proteins 4.0 a and b.
3. No difference can be detected between the protein
composition of normal and sickle membrane skeletons
when analyzed by isoelectric focusing and two-
dimensional electrophoresis (lEF/SDS-PAGE).
4. Several minor quantitative differences can be detected
in the protein organization of normal and sickle
skeletons after treatment with crosslinking reagents.
5. Several quantitative differences can be detected in
proteolytic digestion maps of sickle skeletons when
compared to normal skeletons.
6. Sickle and normal membrane skeletons examined in these
studies were intact and exhibited the morphology and
ultrastructure characteristic of erythrocyte skeletons,
however, no differences were noted.
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